X

Xponance Portfolio holdings

AUM $16.3B Turnover 12.69%
1-Year Est. Return 44.61%
This Fund
S&P 500
This Quarter Est. Return
+13.88%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$9.54B
AUM Growth
+$1.2B
Cap. Flow
+$311M
Cap. Flow %
3.26%
Top 10 Hldgs %
34.78%
Holding
1,336
New
61
Increased
791
Reduced
432
Closed
26
Avg Time Held
2.9 years
Top 10 Avg Time Held
2.8 years
Top 20 Avg Time Held
2.5 years

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$6.87M
2
AAPL icon
Apple
AAPL
+$6.27M
3
NVDA icon
NVIDIA
NVDA
+$5.8M
4
JPM icon
JPMorgan Chase
JPM
+$4.89M
5
WY icon
Weyerhaeuser
WY
+$4.05M

Sector Composition

Rank Sector Weight
1 Technology 33.6%
2 Healthcare 11.85%
3 Consumer Discretionary 11.71%
4 Financials 11.26%
5 Communication Services 9.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
BLUE icon
1301
DELISTED
bluebird bio
BLUE
$15.2K ﹤0.01%
+592
New +$15.2K
2024 Q1
0 quarters
RIGL icon
1302
Rigel Pharmaceuticals
RIGL
$874M
$15K ﹤0.01%
1,012
– –
2023 Q4
1 quarter
DM icon
1303
DELISTED
Desktop Metal, Inc.
DM
$14.4K ﹤0.01%
1,636
– –
2022 Q2
7 quarters
SHCR icon
1304
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
$13.7K ﹤0.01%
17,874
– –
2022 Q3
6 quarters
AGEN icon
1305
Agenus
AGEN
$302M
$13.3K ﹤0.01%
1,151
+43
+4% +$570
2021 Q4
9 quarters
AMWL icon
1306
American Well
AMWL
$207M
$12.3K ﹤0.01%
760
+15
+2% +$322
2022 Q2
7 quarters
GEVO icon
1307
Gevo
GEVO
$294M
$10.1K ﹤0.01%
13,202
+155
+1% +$135
2022 Q2
7 quarters
MVST icon
1308
Microvast
MVST
$205M
$9.96K ﹤0.01%
11,896
– –
2023 Q4
1 quarter
ME icon
1309
DELISTED
23andMe Holding Co
ME
$9.12K ﹤0.01%
858
– –
2022 Q3
6 quarters
WKHS icon
1310
Workhorse Group
WKHS
$31.4M
$2.74K ﹤0.01%
4
– –
2023 Q3
2 quarters
ABCB icon
1311
Ameris Bancorp
ABCB
$5.23B
– –
-3,980
Closed -$211K –
ACAD icon
1312
Acadia Pharmaceuticals
ACAD
$3.29B
– –
-9,552
Closed -$299K –
CALX icon
1313
Calix
CALX
$2.25B
– –
-8,524
Closed -$372K –
CCOI icon
1314
Cogent Communications
CCOI
$404M
– –
-2,661
Closed -$202K –
CNMD icon
1315
CONMED
CNMD
$1.34B
– –
-1,862
Closed -$204K –
CWEN icon
1316
Clearway Energy Class C
CWEN
$3.62B
– –
-7,817
Closed -$214K –
FRSH icon
1317
Freshworks
FRSH
$3.56B
– –
-9,817
Closed -$231K –
HURN icon
1318
Huron Consulting
HURN
$2.8B
– –
-2,617
Closed -$269K –
BRSL icon
1319
Brightstar Lottery PLC
BRSL
$1.75B
– –
-8,697
Closed -$238K –
IJH icon
1320
iShares Core S&P Mid-Cap ETF
IJH
$121B
– –
-9,240
Closed -$512K –
ECHO icon
1321
EchoStar
ECHO
$25.5B
– –
-11,333
Closed -$188K –
SMPL icon
1322
Simply Good Foods
SMPL
$945M
– –
-5,508
Closed -$218K –
SPYV icon
1323
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$36.4B
– –
-9,663
Closed -$451K –
WD icon
1324
Walker & Dunlop
WD
$1.08B
– –
-1,929
Closed -$214K –
UCB icon
1325
United Community Banks
UCB
$3.99B
– –
-7,022
Closed -$205K –

Similar funds

Xponance's Q1 2024 Portfolio in Review

As of Q1 2024, Xponance held 1,336 positions worth $9.54B, up 14% from $8.35B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Xponance deployed $311M of net new capital in Q1 2024, opening 61 new positions and adding to 791 existing holdings. Its largest new stake was Mercado Libre: 2,129 shares worth $3.22M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was iShares Russell 1000 Growth ETF, an estimated $3.06M trimmed.

  • Xponance's largest Q1 2024 buy was Mercado Libre: 2,129 shares worth $3.22M.
  • Xponance added most to Amazon in Q1 2024, an estimated $6.87M increase.
  • Xponance's biggest Q1 2024 reduction was iShares Russell 1000 Growth ETF, cutting an estimated $3.06M.
  • Xponance fully exited Splunk Inc in Q1 2024, selling an estimated $3.19M.
  • Xponance's ten largest holdings make up 35% of its $9.54B portfolio in Q1 2024.
  • Xponance opened 61 new positions and closed 26 in Q1 2024.
  • Xponance's portfolio value rose 14% quarter-over-quarter to $9.54B.

Based on Xponance's 13F filing for Q1 2024, filed 13 May 2024.